Status:
COMPLETED
Efficacy of Intramuscular Naloxone 0.4mg. in Prophylaxis of Intrathecal Morphine Induced Pruritus After Cesarean Section
Lead Sponsor:
Mahidol University
Conditions:
Morphine Adverse Reaction
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether intramuscular naloxone 0.4mg. is effective in prophylaxis of intrathecal morphine induced pruritus after cesarean section.
Eligibility Criteria
Inclusion
- patient schedule for cesarean section ASA class 1
Exclusion
- have contraindication for spinal block
- complicated pregnancy
- have history of drug abuse during pregnancy
- obesity BMI\>35kg./m2
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00890942
Start Date
May 1 2009
End Date
May 1 2010
Last Update
July 25 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anesthesiology department, Siriraj Hospital, Mahidol University
Bangkok, Thailand